EduCare Announces NEW Recurrent and Metastatic Breast Cancer Treatment Handbook
ncarol.com/10031812

CHARLESTON, S.C. - ncarol.com -- For years, recurrent and metastatic breast cancer patients have often felt overlooked. Metastatic breast cancer patients live each day with an incurable disease and must face ongoing treatment regimens as well as intense physical, psychological and emotional issues. Author, Judy C. Kneece, RN, OCN, is excited to release the new Recurrent and Metastatic Breast Cancer Treatment Handbook. She wrote this book to not only educate women about treatments for recurrent and metastatic breast cancer, but just as importantly, she writes about the personal side – the fears, the sorrows, the pain and the choices a woman faces after hearing her diagnosis.

Judy C. Kneece, RN, OCN, states, "This book is about helping you, a recurrent or metastatic patient, take charge of decisions about your life. It offers no guarantees, but it does promise you can live your life fully while dealing with recurrent/metastatic breast cancer if you decide to. You choose what actions you will take – you can make no mistakes. In this area, you are the expert." Her goal is to provide a woman the tools she needs to live her life to the fullest, while fighting this battle.

More on ncarol.com

• Warm, Dry Summer Forecast Points to a Stronger Wasp and Yellowjacket Season Across the Pacific Northwest
• Qscription Technologies Appoints Anurag Velekkatt Sunil Kumar to Drive Enterprise Scale
• SafeBets Named Presenting Sponsor of IMCX 2026, Bringing Its No-Deposit Prediction Platform to the Creator Economy's Deal-Making Conference
• A New Pulse for Cardiac Care in Baltimore: St. Elizabeth Rehab & Nursing Welcomes Dr. Hakim Uqdah and Expands Advanced Heart Program
• Inframark–Slater Joint Venture Selected to Manage Fulton County Wastewater Operations

Based on the premise that well-informed patients make the best patients, the Recurrent and Metastatic Breast Cancer Treatment Handbook covers cancer treatment (types of recurrence, treatment decisions, second opinions, surgical options, reconstruction options, treatment medications and radiation therapy), emotional issues (facing anxiety and depression, helping children cope, communicating with the healthcare team, creating a support team, facing death) and ongoing treatment issues (pain management, insurance, diet and exercise, sexuality problems). The book also has a comprehensive appendix that explains diagnostic tests, chemotherapy drugs and clinical trials.

In her review of the book, Beth Baughman DuPree, MD, FACS, ABOIM wrote, "This handbook will help you navigate the medical, emotional and spiritual challenges you are about to face. Metastatic breast cancer is a 'chronic disease' and there is no way to know what path your cancer journey will follow. Releasing fear and finding peace allows each moment of your life to be savored and appreciated. This is an invaluable guide for every woman facing a metastatic breast cancer diagnosis."

More on ncarol.com

• Cancun International Airport Reports Strong Start to Summer 2026 Travel Season
• Freedomtech Solutions Launches the World's First Pre‑Installed Agentic AI Server — Instant, Sovereign, Infrastructure‑Native Intelligence
• GitKraken Introduces Code Flow, a Framework for Software Development in the Agentic Era
• RIGHT CARS Announces Landmark African Expansion Through Strategic Collaboration Agreement Across Eight Nations
• New from Regal House Publishing, The World to See, high-stakes friendships test women's loyalties

EduCare Inc., a dedicated breast health education company, was founded in January 1994 by Judy C. Kneece, RN, OCN. For more than 25 years, EduCare has been a leader in providing the highest quality breast health educational materials for patients and healthcare providers and in offering continuing training to healthcare professionals.

The Recurrent and Metastatic Breast Cancer Treatment Handbook may be purchased directly through EduCare at www.EduCareInc.com or by phone at 843.760.6064.  It is also available on Amazon.